TreeWAS – Variant ID: rs184148048

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter II Neoplasms	0.253	0.747
C50-C50 Malignant neoplasm of breast	0.249	0.751
C50 Malignant neoplasm of breast	0.247	0.753
O70.1 Second degree perineal laceration during delivery	0.245	0.755
O70 Perineal laceration during delivery	0.244	0.756
O60-O75 Complications of labour and delivery	0.242	0.758
D10-D36 Benign neoplasms	0.236	0.764
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.234	0.766
Chapter XV Pregnancy, childbirth and the puerperium	0.227	0.773
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.223	0.777
C50.9 Breast, unspecified	0.223	0.777
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.222	0.778
# Top node	0.221	0.779
C50.4 Upper-outer quadrant of breast	0.220	0.780
C79 Secondary malignant neoplasm of other sites	0.219	0.781
C51-C58 Malignant neoplasms of female genital organs	0.213	0.787
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.211	0.789
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.210	0.790
D25 Leiomyoma of uterus	0.207	0.793
D12.5 Sigmoid colon	0.207	0.793
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.206	0.794
Chapter VII Diseases of the eye and adnexa	0.205	0.795
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.204	0.796
C50.3 Lower-inner quadrant of breast	0.204	0.796
O70.0 First degree perineal laceration during delivery	0.203	0.797
O72 Postpartum haemorrhage	0.202	0.798
C50.2 Upper-inner quadrant of breast	0.199	0.801
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.199	0.801
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.197	0.803
D60-D64 Aplastic and other anaemias	0.197	0.803
C79.7 Secondary malignant neoplasm of adrenal gland	0.196	0.804
Chapter XX External causes of morbidity and mortality	0.195	0.805
D22 Melanocytic naevi	0.195	0.805
C50.1 Central portion of breast	0.195	0.805
D00-D09 In situ neoplasms	0.194	0.806
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.194	0.806
C34 Malignant neoplasm of bronchus and lung	0.192	0.808
O75 Other complications of labour and delivery, not elsewhere classified	0.191	0.809
O63 Long labour	0.188	0.812
D12.0 Caecum	0.188	0.812
O20-O29 Other maternal disorders predominantly related to pregnancy	0.187	0.812
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.187	0.813
H25-H28 Disorders of lens	0.187	0.813
M45-M49 Spondylopathies	0.184	0.816
M05-M14 Inflammatory polyarthropathies	0.184	0.816
O68 Labour and delivery complicated by foetal stress [distress]	0.184	0.816
D17 Benign lipomatous neoplasm	0.184	0.816
D22.3 Melanocytic naevi of other and unspecified parts of face	0.184	0.816
O64 Obstructed labour due to malposition and malpresentation of foetus	0.183	0.817
O66 Other obstructed labour	0.183	0.817
C50.5 Lower-outer quadrant of breast	0.183	0.817
C79.8 Secondary malignant neoplasm of other specified sites	0.183	0.817
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.182	0.818
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.182	0.818
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.182	0.818
C40-C41 Malignant neoplasms of bone and articular cartilage	0.182	0.818
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.182	0.818
D14 Benign neoplasm of middle ear and respiratory system	0.182	0.818
D36 Benign neoplasm of other and unspecified sites	0.181	0.819
C64-C68 Malignant neoplasms of urinary tract	0.180	0.819
D64 Other anaemias	0.180	0.820
Chapter I Certain infectious and parasitic diseases	0.180	0.820
C73 Malignant neoplasm of thyroid gland	0.180	0.820
C32 Malignant neoplasm of larynx	0.180	0.820
O69 Labour and delivery complicated by umbilical cord complications	0.180	0.820
T36-T50 Poisoning by drugs, medicaments and biological substances	0.180	0.820
D12.3 Transverse colon	0.179	0.821
H26 Other cataract	0.178	0.822
C50.6 Axillary tail of breast	0.177	0.822
C50.0 Nipple and areola	0.177	0.822
D12.7 Rectosigmoid junction	0.175	0.824
O70.9 Perineal laceration during delivery, unspecified	0.175	0.825
O70.3 Fourth degree perineal laceration during delivery	0.175	0.825
O70.2 Third degree perineal laceration during delivery	0.175	0.825
C50.8 Overlapping lesion of breast	0.175	0.825
D33 Benign neoplasm of brain and other parts of central nervous system	0.175	0.825
O74 Complications of anaesthesia during labour and delivery	0.174	0.826
O73 Retained placenta and membranes, without haemorrhage	0.174	0.826
O71 Other obstetric trauma	0.174	0.826
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.174	0.826
O65 Obstructed labour due to maternal pelvic abnormality	0.174	0.826
O62 Abnormalities of forces of labour	0.174	0.826
O61 Failed induction of labour	0.174	0.826
O60 Preterm delivery	0.174	0.826
M20-M25 Other joint disorders	0.174	0.826
H26.9 Cataract, unspecified	0.173	0.827
D35 Benign neoplasm of other and unspecified endocrine glands	0.173	0.827
A00-A09 Intestinal infectious diseases	0.172	0.828
C51 Malignant neoplasm of vulva	0.171	0.829
D37-D48 Neoplasms of uncertain or unknown behaviour	0.171	0.829
D34 Benign neoplasm of thyroid gland	0.171	0.829
O80-O84 Delivery	0.171	0.829
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.170	0.829
C56 Malignant neoplasm of ovary	0.170	0.830
C90 Multiple myeloma and malignant plasma cell neoplasms	0.169	0.830
D64.9 Anaemia, unspecified	0.169	0.831
D32 Benign neoplasm of meninges	0.169	0.831
D31 Benign neoplasm of eye and adnexa	0.169	0.831
D30 Benign neoplasm of urinary organs	0.169	0.831
D29 Benign neoplasm of male genital organs	0.169	0.831
D28 Benign neoplasm of other and unspecified female genital organs	0.169	0.831
D26 Other benign neoplasms of uterus	0.169	0.831
D21 Other benign neoplasms of connective and other soft tissue	0.169	0.831
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.169	0.831
D19 Benign neoplasm of mesothelial tissue	0.169	0.831
D16 Benign neoplasm of bone and articular cartilage	0.169	0.831
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.169	0.831
D10 Benign neoplasm of mouth and pharynx	0.169	0.831
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.169	0.831
M40-M43 Deforming dorsopathies	0.168	0.831
S80-S89 Injuries to the knee and lower leg	0.168	0.832
D25.0 Submucous leiomyoma of uterus	0.168	0.832
C80 Malignant neoplasm without specification of site	0.168	0.832
C76 Malignant neoplasm of other and ill-defined sites	0.168	0.832
D11 Benign neoplasm of major salivary glands	0.167	0.833
C78.7 Secondary malignant neoplasm of liver	0.166	0.834
O72.0 Third-stage haemorrhage	0.165	0.835
D69 Purpura and other haemorrhagic conditions	0.165	0.835
M06 Other rheumatoid arthritis	0.165	0.835
M23 Internal derangement of knee	0.164	0.836
D25.1 Intramural leiomyoma of uterus	0.164	0.836
O00-O08 Pregnancy with abortive outcome	0.164	0.836
D12.2 Ascending colon	0.163	0.837
O85-O92 Complications predominantly related to the puerperium	0.163	0.837
D62 Acute posthaemorrhagic anaemia	0.162	0.837
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.162	0.838
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.161	0.839
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.161	0.839
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.160	0.840
C38 Malignant neoplasm of heart, mediastinum and pleura	0.160	0.840
C31 Malignant neoplasm of accessory sinuses	0.160	0.840
C30 Malignant neoplasm of nasal cavity and middle ear	0.160	0.840
C37 Malignant neoplasm of thymus	0.160	0.840
C33 Malignant neoplasm of trachea	0.160	0.840
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.160	0.840
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.160	0.840
D12.9 Anus and anal canal	0.160	0.840
D12.1 Appendix	0.160	0.840
M23.2 Derangement of meniscus due to old tear or injury	0.160	0.840
C34.9 Bronchus or lung, unspecified	0.160	0.840
M80-M85 Disorders of bone density and structure	0.159	0.841
Chapter XVI Certain conditions originating in the perinatal period	0.159	0.841
D25.9 Leiomyoma of uterus, unspecified	0.159	0.841
D80-D89 Certain disorders involving the immune mechanism	0.158	0.842
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.158	0.842
M86-M90 Other osteopathies	0.158	0.842
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.158	0.842
D25.2 Subserosal leiomyoma of uterus	0.157	0.842
C71 Malignant neoplasm of brain	0.157	0.843
C79.9 Secondary malignant neoplasm, unspecified site	0.157	0.843
C79.6 Secondary malignant neoplasm of ovary	0.157	0.843
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.157	0.843
C79.2 Secondary malignant neoplasm of skin	0.157	0.843
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.157	0.843
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.157	0.843
T66-T78 Other and unspecified effects of external causes	0.157	0.843
Chapter XXII Codes for special purposes	0.157	0.843
O72.1 Other immediate postpartum haemorrhage	0.156	0.844
C54 Malignant neoplasm of corpus uteri	0.156	0.844
M10 Gout	0.156	0.844
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.155	0.844
D05 Carcinoma in situ of breast	0.155	0.844
O75.2 Pyrexia during labour, not elsewhere classified	0.154	0.846
H40-H42 Glaucoma	0.154	0.846
A09.9 Gastroenteritis and colitis of unspecified origin	0.154	0.846
M46 Other inflammatory spondylopathies	0.153	0.846
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.153	0.847
C57 Malignant neoplasm of other and unspecified female genital organs	0.153	0.847
C53 Malignant neoplasm of cervix uteri	0.153	0.847
C58 Malignant neoplasm of placenta	0.153	0.847
C55 Malignant neoplasm of uterus, part unspecified	0.153	0.847
C52 Malignant neoplasm of vagina	0.153	0.847
C34.3 Lower lobe, bronchus or lung	0.153	0.847
D12.6 Colon, unspecified	0.153	0.847
H43-H45 Disorders of vitreous body and globe	0.152	0.848
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.152	0.848
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.152	0.848
S00-S09 Injuries to the head	0.152	0.848
O26 Maternal care for other conditions predominantly related to pregnancy	0.151	0.848
C75 Malignant neoplasm of other endocrine glands and related structures	0.151	0.849
C74 Malignant neoplasm of adrenal gland	0.151	0.849
C78.0 Secondary malignant neoplasm of lung	0.151	0.849
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.151	0.849
D55-D59 Haemolytic anaemias	0.150	0.849
V20-V29 Motorcycle rider injured in transport accident	0.150	0.850
H53-H54 Visual disturbances and blindness	0.150	0.850
O63.1 Prolonged second stage (of labour)	0.150	0.850
C64 Malignant neoplasm of kidney, except renal pelvis	0.149	0.851
C32.0 Glottis	0.149	0.851
T15-T19 Effects of foreign body entering through natural orifice	0.149	0.851
D68 Other coagulation defects	0.149	0.851
H27 Other disorders of lens	0.148	0.852
M47 Spondylosis	0.148	0.852
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.148	0.852
M91-M94 Chondropathies	0.148	0.852
M60-M63 Disorders of muscles	0.148	0.852
M00-M03 Infectious arthropathies	0.148	0.852
M65-M68 Disorders of synovium and tendon	0.148	0.852
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)	0.148	0.852
H55-H59 Other disorders of eye and adnexa	0.147	0.853
H46-H48 Disorders of optic nerve and visual pathways	0.147	0.853
H10-H13 Disorders of conjunctiva	0.147	0.853
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.146	0.854
C95 Leukaemia of unspecified cell type	0.146	0.854
C94 Other leukaemias of specified cell type	0.146	0.854
C93 Monocytic leukaemia	0.146	0.854
C92 Myeloid leukaemia	0.146	0.854
C88 Malignant immunoproliferative diseases	0.146	0.854
C86 Other specified types of T/NK-cell lymphoma	0.146	0.854
C84 Peripheral and cutaneous T-cell lymphomas	0.146	0.854
C81 Hodgkin's disease	0.146	0.854
M48 Other spondylopathies	0.146	0.854
O20 Haemorrhage in early pregnancy	0.146	0.854
D18 Haemangioma and lymphangioma, any site	0.146	0.854
M06.9 Rheumatoid arthritis, unspecified	0.146	0.854
D63 Anaemia in chronic diseases classified elsewhere	0.145	0.855
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.145	0.855
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.145	0.855
C90.0 Multiple myeloma	0.145	0.855
C83 Diffuse non-Hodgkin's lymphoma	0.145	0.855
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.145	0.855
O72.3 Postpartum coagulation defects	0.145	0.855
O72.2 Delayed and secondary postpartum haemorrhage	0.145	0.855
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.145	0.855
S40-S49 Injuries to the shoulder and upper arm	0.144	0.856
S70-S79 Injuries to the hip and thigh	0.144	0.856
D70-D77 Other diseases of blood and blood-forming organs	0.144	0.856
W20-W49 Exposure to inanimate mechanical forces	0.144	0.856
D17.9 Benign lipomatous neoplasm, unspecified	0.144	0.856
X60-X84 Intentional self-harm	0.143	0.857
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.143	0.857
S50-S59 Injuries to the elbow and forearm	0.143	0.857
D14.0 Middle ear, nasal cavity and accessory sinuses	0.143	0.857
T79-T79 Certain early complications of trauma	0.143	0.857
T33-T35 Frostbite	0.143	0.857
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.143	0.857
T26-T28 Burns and corrosions confined to eye and internal organs	0.143	0.857
T20-T25 Burns and corrosions of external body surface, specified by site	0.143	0.857
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.143	0.857
T00-T07 Injuries involving multiple body regions	0.143	0.857
S90-S99 Injuries to the ankle and foot	0.143	0.857
S10-S19 Injuries to the neck	0.143	0.857
D22.6 Melanocytic naevi of upper limb, including shoulder	0.143	0.857
D36.1 Peripheral nerves and autonomic nervous system	0.143	0.857
Y60-Y69 Misadventures to patients during surgical and medical care	0.142	0.858
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.142	0.858
C70 Malignant neoplasm of meninges	0.142	0.858
C69 Malignant neoplasm of eye and adnexa	0.142	0.858
M43 Other deforming dorsopathies	0.141	0.858
C51.9 Vulva, unspecified	0.141	0.859
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.141	0.859
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.141	0.859
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.140	0.859
T43.2 Other and unspecified antidepressants	0.141	0.859
M05 Seropositive rheumatoid arthritis	0.140	0.859
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.140	0.860
Y35-Y36 Legal intervention and operations of war	0.140	0.860
Y10-Y34 Event of undetermined intent	0.140	0.860
Y00-Y09 Assault	0.140	0.860
X85-X99 Assault	0.140	0.860
X58-X59 Accidental exposure to other and unspecified factors	0.140	0.860
X50-X57 Overexertion, travel and privation	0.140	0.860
X40-X49 Accidental poisoning by and exposure to noxious substances	0.140	0.860
X30-X39 Exposure to forces of nature	0.140	0.860
X20-X29 Contact with venomous animals and plants	0.140	0.860
X10-X19 Contact with heat and hot substances	0.140	0.860
X00-X09 Exposure to smoke, fire and flames	0.140	0.860
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.140	0.860
W75-W84 Other accidental threats to breathing	0.140	0.860
W65-W74 Accidental drowning and submersion	0.140	0.860
W50-W64 Exposure to animate mechanical forces	0.140	0.860
V98-V99 Other and unspecified transport accidents	0.140	0.860
V95-V97 Air and space transport accidents	0.140	0.860
V90-V94 Water transport accidents	0.140	0.860
V80-V89 Other land transport accidents	0.140	0.860
V70-V79 Bus occupant injured in transport accident	0.140	0.860
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.140	0.860
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.140	0.860
V40-V49 Car occupant injured in transport accident	0.140	0.860
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.140	0.860
V10-V19 Pedal cyclist injured in transport accident	0.140	0.860
V01-V09 Pedestrian injured in transport accident	0.140	0.860
D22.9 Melanocytic naevi, unspecified	0.140	0.860
D22.2 Melanocytic naevi of ear and external auricular canal	0.140	0.860
D22.1 Melanocytic naevi of eyelid, including canthus	0.140	0.860
D22.0 Melanocytic naevi of lip	0.140	0.860
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.140	0.860
C34.1 Upper lobe, bronchus or lung	0.139	0.861
A04 Other bacterial intestinal infections	0.139	0.861
D09 Carcinoma in situ of other and unspecified sites	0.139	0.861
D07 Carcinoma in situ of other and unspecified genital organs	0.139	0.861
D04 Carcinoma in situ of skin	0.139	0.861
D03 Melanoma in situ	0.139	0.861
D02 Carcinoma in situ of middle ear and respiratory system	0.139	0.861
D01 Carcinoma in situ of other and unspecified digestive organs	0.139	0.861
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.139	0.861
D61 Other aplastic anaemias	0.139	0.861
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.139	0.861
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.139	0.861
C78.4 Secondary malignant neoplasm of small intestine	0.139	0.861
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.139	0.861
C78.1 Secondary malignant neoplasm of mediastinum	0.139	0.861
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.138	0.861
D69.6 Thrombocytopenia, unspecified	0.138	0.862
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.138	0.862
C91 Lymphoid leukaemia	0.138	0.862
D12.8 Rectum	0.138	0.862
D69.3 Idiopathic thrombocytopenic purpura	0.138	0.862
C34.8 Overlapping lesion of bronchus and lung	0.138	0.862
C34.2 Middle lobe, bronchus or lung	0.138	0.862
C34.0 Main bronchus	0.138	0.862
O75.9 Complication of labour and delivery, unspecified	0.137	0.863
O75.8 Other specified complications of labour and delivery	0.137	0.863
O75.7 Vaginal delivery following previous Caesarean section	0.137	0.863
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.137	0.863
O75.5 Delayed delivery after artificial rupture of membranes	0.137	0.863
O75.4 Other complications of obstetric surgery and procedures	0.137	0.863
O75.3 Other infection during labour	0.137	0.863
O75.1 Shock during or following labour and delivery	0.137	0.863
O75.0 Maternal distress during labour and delivery	0.137	0.863
D22.4 Melanocytic naevi of scalp and neck	0.137	0.863
S81 Open wound of lower leg	0.137	0.863
S20-S29 Injuries to the thorax	0.136	0.864
Chapter XIV Diseases of the genitourinary system	0.136	0.864
O94-O99 Other obstetric conditions, not elsewhere classified	0.135	0.864
M10.9 Gout, unspecified	0.135	0.864
O69.2 Labour and delivery complicated by other cord entanglement	0.135	0.865
Y86 Sequelae of other accidents	0.135	0.865
M07 Psoriatic and enteropathic arthropathies	0.135	0.865
O63.9 Long labour, unspecified	0.135	0.865
O63.2 Delayed delivery of second twin, triplet, etc.	0.135	0.865
O63.0 Prolonged first stage (of labour)	0.135	0.865
S60-S69 Injuries to the wrist and hand	0.135	0.865
O29 Complications of anaesthesia during pregnancy	0.134	0.865
O28 Abnormal findings on antenatal screening of mother	0.134	0.865
O24 Diabetes mellitus in pregnancy	0.134	0.865
O23 Infections of genito-urinary tract in pregnancy	0.134	0.865
O22 Venous complications in pregnancy	0.134	0.865
O21 Excessive vomiting in pregnancy	0.134	0.865
O25 Malnutrition in pregnancy	0.134	0.865
D67 Hereditary factor IX deficiency	0.134	0.865
D66 Hereditary factor VIII deficiency	0.134	0.865
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.134	0.865
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.134	0.866
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.134	0.866
M21 Other acquired deformities of limbs	0.134	0.866
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.134	0.866
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.134	0.866
Y40 Systemic antibiotics	0.133	0.867
D06 Carcinoma in situ of cervix uteri	0.133	0.867
M49 Spondylopathies in diseases classified elsewhere	0.132	0.868
M45 Ankylosing spondylitis	0.132	0.868
M06.0 Seronegative rheumatoid arthritis	0.132	0.868
M14 Arthropathies in other diseases classified elsewhere	0.132	0.868
M12 Other specific arthropathies	0.132	0.868
M11 Other crystal arthropathies	0.132	0.868
M09 Juvenile arthritis in diseases classified elsewhere	0.132	0.868
M08 Juvenile arthritis	0.132	0.868
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.132	0.868
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.132	0.868
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.132	0.868
D17.7 Benign lipomatous neoplasm of other sites	0.132	0.868
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.132	0.868
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.132	0.868
D05.9 Carcinoma in situ of breast, unspecified	0.132	0.868
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.132	0.868
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.132	0.868
H30-H36 Disorders of choroid and retina	0.132	0.868
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.132	0.868
S82 Fracture of lower leg, including ankle	0.131	0.868
M23.22 Derangement of meniscus due to old tear or injury (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.132	0.868
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.131	0.868
O64.8 Obstructed labour due to other malposition and malpresentation	0.131	0.868
O64.5 Obstructed labour due to compound presentation	0.131	0.868
O64.4 Obstructed labour due to shoulder presentation	0.131	0.868
O64.3 Obstructed labour due to brow presentation	0.131	0.868
O64.2 Obstructed labour due to face presentation	0.131	0.868
O64.1 Obstructed labour due to breech presentation	0.131	0.868
M46.9 Inflammatory spondylopathy, unspecified	0.131	0.869
O66.9 Obstructed labour, unspecified	0.131	0.869
O66.8 Other specified obstructed labour	0.131	0.869
O66.4 Failed trial of labour, unspecified	0.131	0.869
O66.3 Obstructed labour due to other abnormalities of foetus	0.131	0.869
O66.2 Obstructed labour due to unusually large foetus	0.131	0.869
O66.1 Obstructed labour due to locked twins	0.131	0.869
O66.0 Obstructed labour due to shoulder dystocia	0.131	0.869
D35.2 Pituitary gland	0.131	0.869
D33.3 Cranial nerves	0.131	0.869
B35-B49 Mycoses	0.131	0.869
O80 Single spontaneous delivery	0.131	0.869
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.130	0.869
C13 Malignant neoplasm of hypopharynx	0.130	0.869
C11 Malignant neoplasm of nasopharynx	0.130	0.869
C10 Malignant neoplasm of oropharynx	0.130	0.869
C09 Malignant neoplasm of tonsil	0.130	0.869
C08 Malignant neoplasm of other and unspecified major salivary glands	0.130	0.869
C06 Malignant neoplasm of other and unspecified parts of mouth	0.130	0.869
C05 Malignant neoplasm of palate	0.130	0.869
C04 Malignant neoplasm of floor of mouth	0.130	0.869
C03 Malignant neoplasm of gum	0.130	0.869
C02 Malignant neoplasm of other and unspecified parts of tongue	0.130	0.869
C00 Malignant neoplasm of lip	0.130	0.869
C12 Malignant neoplasm of pyriform sinus	0.130	0.869
C07 Malignant neoplasm of parotid gland	0.130	0.869
C01 Malignant neoplasm of base of tongue	0.130	0.869
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.130	0.869
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.130	0.869
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.130	0.869
C49 Malignant neoplasm of other connective and soft tissue	0.130	0.869
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.130	0.869
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.130	0.869
C46 Kaposi's sarcoma	0.130	0.869
C45 Mesothelioma	0.130	0.869
C97 Malignant neoplasms of independent (primary) multiple sites	0.130	0.869
D14.4 Respiratory system, unspecified	0.130	0.869
D14.3 Bronchus and lung	0.130	0.869
D14.2 Trachea	0.130	0.869
D14.1 Larynx	0.130	0.869
D36.9 Benign neoplasm of unspecified site	0.130	0.870
D36.7 Other specified sites	0.130	0.870
D36.0 Lymph nodes	0.130	0.870
A08 Viral and other specified intestinal infections	0.130	0.870
C68 Malignant neoplasm of other and unspecified urinary organs	0.129	0.870
C66 Malignant neoplasm of ureter	0.129	0.870
C65 Malignant neoplasm of renal pelvis	0.129	0.870
D64.8 Other specified anaemias	0.129	0.870
D64.4 Congenital dyserythropoietic anaemia	0.129	0.870
D64.3 Other sideroblastic anaemias	0.129	0.870
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.129	0.870
D64.1 Secondary sideroblastic anaemia due to disease	0.129	0.870
D64.0 Hereditary sideroblastic anaemia	0.129	0.870
B99-B99 Other infectious diseases	0.129	0.870
B90-B94 Sequelae of infectious and parasitic diseases	0.129	0.870
B85-B89 Pediculosis, acariasis and other infestations	0.129	0.870
B65-B83 Helminthiases	0.129	0.870
B50-B64 Protozoal diseases	0.129	0.870
B20-B24 Human immunodeficiency virus [HIV] disease	0.129	0.870
B15-B19 Viral hepatitis	0.129	0.870
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.129	0.870
A80-A89 Viral infections of the central nervous system	0.129	0.870
A75-A79 Rickettsioses	0.129	0.870
A70-A74 Other diseases caused by chlamydiae	0.129	0.870
A65-A69 Other spirochaetal diseases	0.129	0.870
A50-A64 Infections with a predominantly sexual mode of transmission	0.129	0.870
A20-A28 Certain zoonotic bacterial diseases	0.129	0.870
A15-A19 Tuberculosis	0.129	0.870
C32.9 Larynx, unspecified	0.129	0.871
C32.8 Overlapping lesion of larynx	0.129	0.871
C32.3 Laryngeal cartilage	0.129	0.871
C32.2 Subglottis	0.129	0.871
C32.1 Supraglottis	0.129	0.871
C85.1 B-cell lymphoma, unspecified	0.129	0.871
H16 Keratitis	0.129	0.871
O69.9 Labour and delivery complicated by cord complication, unspecified	0.129	0.871
O69.8 Labour and delivery complicated by other cord complications	0.129	0.871
O69.5 Labour and delivery complicated by vascular lesion of cord	0.129	0.871
O69.4 Labour and delivery complicated by vasa praevia	0.129	0.871
O69.3 Labour and delivery complicated by short cord	0.129	0.871
O69.1 Labour and delivery complicated by cord around neck, with compression	0.129	0.871
O69.0 Labour and delivery complicated by prolapse of cord	0.129	0.871
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.129	0.871
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.129	0.871
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.129	0.871
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.129	0.871
T46 Poisoning by agents primarily affecting the cardiovascular system	0.129	0.871
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.129	0.871
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.129	0.871
T41 Poisoning by anaesthetics and therapeutic gases	0.129	0.871
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.129	0.871
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.129	0.871
T36 Poisoning by systemic antibiotics	0.129	0.871
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.129	0.871
N30-N39 Other diseases of urinary system	0.128	0.871
C78.2 Secondary malignant neoplasm of pleura	0.128	0.872
D22.7 Melanocytic naevi of lower limb, including hip	0.128	0.872
M70-M79 Other soft tissue disorders	0.128	0.872
D27 Benign neoplasm of ovary	0.128	0.872
M22 Disorders of patella	0.128	0.872
H26.8 Other specified cataract	0.128	0.872
H26.3 Drug-induced cataract	0.128	0.872
H26.2 Complicated cataract	0.128	0.872
H26.1 Traumatic cataract	0.128	0.872
H26.0 Infantile, juvenile and presenile cataract	0.128	0.872
M84 Disorders of continuity of bone	0.127	0.873
T78 Adverse effects, not elsewhere classified	0.127	0.873
O03 Spontaneous abortion	0.127	0.873
B25-B34 Other viral diseases	0.127	0.873
W00-W19 Falls	0.127	0.873
C71.2 Temporal lobe	0.126	0.873
D12.4 Descending colon	0.126	0.874
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.126	0.874
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.126	0.874
Chapter V Mental and behavioural disorders	0.126	0.874
D33.9 Central nervous system, unspecified	0.125	0.874
D33.7 Other specified parts of central nervous system	0.125	0.874
D33.4 Spinal cord	0.125	0.874
D33.2 Brain, unspecified	0.125	0.874
D33.1 Brain, infratentorial	0.125	0.874
D33.0 Brain, supratentorial	0.125	0.874
M31 Other necrotising vasculopathies	0.125	0.875

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations